The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2,3,4,5-tetrachloro-6-(4,5-di(1,3,2-dithiarsolan-2-yl)-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid ID: ALA4129564
PubChem CID: 145960745
Max Phase: Preclinical
Molecular Formula: C24H14As2Cl4O5S4
Molecular Weight: 802.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2ccc(=O)c([As]3SCCS3)c-2oc2c([As]3SCCS3)c(O)ccc12
Standard InChI: InChI=1S/C24H14As2Cl4O5S4/c27-18-14(15(24(33)34)19(28)21(30)20(18)29)13-9-1-3-11(31)16(25-36-5-6-37-25)22(9)35-23-10(13)2-4-12(32)17(23)26-38-7-8-39-26/h1-4,31H,5-8H2,(H,33,34)
Standard InChI Key: IRYFURIWRJWDQS-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 44 0 0 0 0 0 0 0 0999 V2000
29.3835 -13.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3824 -14.2488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0983 -14.6640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8158 -14.2483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8129 -13.4172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0965 -13.0099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0964 -12.1878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0971 -10.5375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.8120 -10.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8121 -11.7741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5224 -12.1858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2372 -11.7739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2372 -10.9499 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5223 -10.5376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3798 -11.7773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3836 -10.9518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6712 -10.5395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9585 -10.9476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9586 -11.7762 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6675 -12.1890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9531 -10.5397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.5211 -9.7121 0.0000 As 0 0 0 0 0 3 0 0 0 0 0 0
28.6741 -9.7140 0.0000 As 0 0 0 0 0 3 0 0 0 0 0 0
27.2437 -10.5356 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.3472 -9.2304 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
29.0961 -8.4441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2704 -8.4412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0140 -9.2257 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
32.1884 -9.2302 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.9292 -8.4452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1036 -8.4464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8511 -9.2322 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.5269 -13.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2440 -13.4119 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.2351 -12.5870 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.6726 -13.0094 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
28.6703 -14.6583 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
30.0981 -15.4855 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
31.5282 -14.6573 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 10 2 0
7 15 1 0
9 8 1 0
8 16 1 0
6 7 1 0
9 10 1 0
9 14 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
13 21 2 0
14 22 1 0
17 23 1 0
18 24 1 0
23 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 23 1 0
22 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 22 1 0
5 33 1 0
33 34 1 0
33 35 2 0
1 36 1 0
2 37 1 0
3 38 1 0
4 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 802.29Molecular Weight (Monoisotopic): 799.6910AlogP: ┄#Rotatable Bonds: ┄Polar Surface Area: ┄Molecular Species: ┄HBA: ┄HBD: ┄#RO5 Violations: ┄HBA (Lipinski): ┄HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: ┄CX LogD: ┄Aromatic Rings: ┄Heavy Atoms: ┄QED Weighted: ┄Np Likeness Score: ┄
References 1. Korntner S, Pomorski A, Krężel A, Bishop AC.. (2018) Optimized allosteric inhibition of engineered protein tyrosine phosphatases with an expanded palette of biarsenical small molecules., 26 (9): [PMID:29673715 ] [10.1016/j.bmc.2018.04.026 ]